Pharmaceutical Glass Packaging Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global pharmaceutical glass packaging market size was estimated at USD 19.75 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2031.
The global pharmaceutical glass packaging market is poised for significant growth over the forecast period 2024-2031, with syringes emerging as the most attractive product type for incremental opportunities. According to recent market analysis, syringes are projected to witness a remarkable increase in market share by 2031. Concurrently, ampoules and vials are expected to create an incremental opportunity, expanding at a Compound Annual Growth Rate (CAGR) of 3% by the end of the forecast period.
Challenges in North America and Latin America
The North American market faces challenges due to product recalls attributed to glass breakages in ampoules, vials, and syringes, leading to an unstable scenario. Instances of recalls, such as the EPREX prefillable syringes due to leachable causing adverse effects in patients, underscore the importance of stringent quality control measures. Similarly, glass breakage concerns prompted recalls by major pharmaceutical companies like Amgen and Johnson & Johnson, highlighting the necessity for enhanced safety standards.
In Latin America, despite high demand for ampoules and vials, the market grapples with glass delamination issues, hindering the deployment of glass packaging products. Although countries like Brazil and Mexico lead in consumption, concerns over glass chipping and surface degradation pose challenges to long-term sustainability. However, advancements in polymer-based packaging offer promising solutions, offering higher resistance to delamination, prolonged shelf life, and cost-effectiveness.
Rising Opportunities in Asia Pacific
The Asia Pacific region presents promising growth opportunities, driven by the introduction of new therapeutic drugs administered in ampoules and prefilled syringes. With a surge in approvals for biologics and biosimilars, the demand for pharmaceutical glass packaging products is expected to escalate. Over 60 types of parenteral drugs and vaccines are currently available in prefilled syringes, with a wide range of drug classes, including insulin, interferon, and monoclonal antibodies, driving market expansion. Moreover, patent expirations of biologics have paved the way for biosimilars, further fueling the adoption of glass packaging in the region.
As the pharmaceutical industry continues to evolve, the market for glass packaging remains dynamic, with opportunities for innovation and growth. Stakeholders are urged to prioritize quality assurance measures and explore emerging technologies to address existing challenges and capitalize on evolving market trends.
Competitive Analysis
Key companies functioning in the global pharmaceutical glass packaging market including:
• Schott AG
• Gerresheimer AG
• Becton, Dickinson and Company
• Owens-Illinois, Inc.
• Ardagh Group S.A.
• Nipro Corporation
• West Pharmaceutical Services, Inc.
• Stevanato Group (Ompi)
• O.Berk Company, LLC
• ?i?ecam Group
• DWK Life Sciences GmbH
• Beatson Clark Ltd.
• Piramal Glass Limited
• Acme Vial and Glass Company, LLC
• Amposan S.A.
• SGD Pharma
• Hindusthan National Glass & Industries Limited
• Shandong Pharmaceutical Glass Co., Ltd.
• Bormioli Pharma Srl
• Agrado S.A.
• Others.
Pharmaceutical Glass Packaging Market: Segment Overview
By Product
• Bottles
• Syringes
• Ampoules and Vials
• Cartridges
Application
• Oral
• Injectable
• Nasal
• Others (Topical, etc.)
Material Type
• Type I
• Type II
• Type III
Region
• North America
• Latin America
• Asia Pacific
• Europe
• MEA
Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.